Literature DB >> 14667822

Fkbp8: novel isoforms, genomic organization, and characterization of a forebrain promoter in transgenic mice.

Jakob V Nielsen1, Cathy Mitchelmore, Karen M Pedersen, Karen M Kjaerulff, Bente Finsen, Niels A Jensen.   

Abstract

The immunophilin homolog FKBP8 has been implicated in the regulation of apoptosis. Here we show that the 38-kDa form of FKBP8 (FKBP38) derives from a truncated ORF. The extended FKBP8 ORFs are 46 and 44 kDa in mouse and 45 kDa in human. Although the genomic organization of mouse and human FKBP8 is evolutionarily conserved, additional first exons are encoded by the murine locus. A 4.4-kb murine Fkbp8 gene fragment, containing a GC-rich potential promoter, directed expression of a LacZ reporter gene to forebrain neurons in transgenic mice. Expression of the transgene was observed in CA1 pyramidal neurons of the hippocampus in transgenic mice from three lines. One transgenic founder mouse exhibited widespread forebrain expression of the LacZ transgene that resembles the pattern for the endogenous Fkbp8 gene. Thus promoter/enhancer elements for forebrain expression are located around the first exons of the mouse Fkbp8 gene.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14667822     DOI: 10.1016/j.ygeno.2003.07.001

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  12 in total

1.  Characterization of a Bcl-XL-interacting protein FKBP8 and its splice variant in human RPE cells.

Authors:  Yan Chen; Paul Sternberg; Jiyang Cai
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

2.  FK506 binding protein 8 peptidylprolyl isomerase activity manages a late stage of cystic fibrosis transmembrane conductance regulator (CFTR) folding and stability.

Authors:  Darren M Hutt; Daniela Martino Roth; Monica A Chalfant; Robert T Youker; Jeanne Matteson; Jeffrey L Brodsky; William E Balch
Journal:  J Biol Chem       Date:  2012-04-02       Impact factor: 5.157

3.  FKBP38 peptidylprolyl isomerase promotes the folding of cystic fibrosis transmembrane conductance regulator in the endoplasmic reticulum.

Authors:  Yeshavanth K Banasavadi-Siddegowda; Junbo Mai; Yifei Fan; Sumit Bhattacharya; David R Giovannucci; Edwin R Sanchez; Gunter Fischer; Xiaodong Wang
Journal:  J Biol Chem       Date:  2011-10-26       Impact factor: 5.157

Review 4.  Bending tau into shape: the emerging role of peptidyl-prolyl isomerases in tauopathies.

Authors:  John Koren; Umesh K Jinwal; Zachary Davey; Janine Kiray; Karthik Arulselvam; Chad A Dickey
Journal:  Mol Neurobiol       Date:  2011-04-28       Impact factor: 5.590

5.  FKBP8 interact with classical swine fever virus NS5A protein and promote virus RNA replication.

Authors:  Helin Li; Chengcheng Zhang; Hongjie Cui; Kangkang Guo; Fang Wang; Tianyue Zhao; Wulong Liang; Qizhuang Lv; Yanming Zhang
Journal:  Virus Genes       Date:  2016-01-09       Impact factor: 2.332

Review 6.  Key factors in mTOR regulation.

Authors:  Xiaochun Bai; Yu Jiang
Journal:  Cell Mol Life Sci       Date:  2009-10-13       Impact factor: 9.261

7.  The switch I region of Rheb is critical for its interaction with FKBP38.

Authors:  Dongzhu Ma; Xiaochun Bai; Shuguang Guo; Yu Jiang
Journal:  J Biol Chem       Date:  2008-07-25       Impact factor: 5.157

8.  Role of the ANKMY2-FKBP38 axis in regulation of the Sonic hedgehog (Shh) signaling pathway.

Authors:  Shotaro Saita; Michiko Shirane; Tohru Ishitani; Nobuyuki Shimizu; Keiichi I Nakayama
Journal:  J Biol Chem       Date:  2014-07-30       Impact factor: 5.157

9.  Hereditary spastic paraplegia and amyotrophy associated with a novel locus on chromosome 19.

Authors:  K G Meilleur; M Traoré; M Sangaré; A Britton; G Landouré; S Coulibaly; B Niaré; F Mochel; A La Pean; I Rafferty; C Watts; D Shriner; M T Littleton-Kearney; C Blackstone; A Singleton; K H Fischbeck
Journal:  Neurogenetics       Date:  2009-12-29       Impact factor: 2.660

10.  Hepatitis C virus RNA replication is regulated by FKBP8 and Hsp90.

Authors:  Toru Okamoto; Yorihiro Nishimura; Tohru Ichimura; Kensuke Suzuki; Tatsuo Miyamura; Tetsuro Suzuki; Kohji Moriishi; Yoshiharu Matsuura
Journal:  EMBO J       Date:  2006-10-05       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.